Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database
Serum insulin-like growth factor-1 (IGF-I) and IGF binding protein-3 (IGFBP-3) levels can be used to monitor the safety of recombinant human growth hormone (rhGH) therapy. In this study, we evaluated the changes in serum IGF-I and IGFBP-3 levels during rhGH therapy as a marker of height outcome in p...
Guardado en:
Autores principales: | Minsun Kim, Eun Young Kim, Cheol Hwan So, Chan Jong Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea54cec9de4f4f20af2fbf43945bfda5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database.
por: Minsun Kim, et al.
Publicado: (2021) -
Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
por: Ewelina Witkowska-Sędek, et al.
Publicado: (2021) -
Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: Juan Li, et al.
Publicado: (2021) -
Factors affecting IGF-I level and correlation with growth response during growth hormone treatment in LG Growth Study.
por: Ji Hyun Kim, et al.
Publicado: (2021) -
Expression of genes encoding IGF1, IGF2, and IGFBPs in blood of obese adolescents with insulin resistance
por: Minchenko Dmytro O., et al.
Publicado: (2019)